Structure-aided optimization of kinase inhibitors derived from alsterpaullone.
about
Glycogen synthase kinase 3: more than a namesakeEstablished Stem Cell Model of Spinal Muscular Atrophy Is Applicable in the Evaluation of the Efficacy of Thyrotropin-Releasing Hormone Analog.A screen for regulators of survival of motor neuron protein levelsRuthenium- and Osmium-Arene Complexes of 2-Substituted Indolo[3,2-c]quinolines: Synthesis, Structure, Spectroscopic Properties, and Antiproliferative Activity.In silico pharmacology for drug discovery: applications to targets and beyondAntagonistic Relationship between Human Cytomegalovirus pUL27 and pUL97 Activities during Infection.Small-Molecule Inhibitors of GSK-3: Structural Insights and Their Application to Alzheimer's Disease ModelsMetal-Arene Complexes with Indolo[3,2-c]-quinolines: Effects of Ruthenium vs Osmium and Modifications of the Lactam Unit on Intermolecular Interactions, Anticancer Activity, Cell Cycle, and Cellular Accumulation.Glycogen synthase kinase 3 is a potential drug target for African trypanosomiasis therapy.The hunt for antimitotic agents: an overview of structure-based design strategies.Ruthenium- and osmium-arene complexes of 8-substituted indolo[3,2-c]quinolines: Synthesis, X-ray diffraction structures, spectroscopic properties, and antiproliferative activity.Impact of Cyclin B2 and Cell division cycle 2 on tubular hyperplasia in progressive chronic renal failure rats10-iodo-11H-indolo[3,2-c]quinoline-6-carboxylic acids are selective inhibitors of DYRK1A.Synthesis of 7-alkylidene-7,12-dihydroindolo[3,2-d]benzazepine-6-(5H)-ones (7-alkylidene-paullones) by N-cyclization–oxidative Heck cascade and characterization as sirtuin modulators
P2860
Q24315635-3EC234C5-C461-4763-B964-BFF79E9FECC5Q30702451-478C4620-5FF2-4E6A-ADF1-0E8D0106EF74Q33936321-A8A0148C-09E6-448F-92E2-3CCE9D57FA2EQ34498243-BF84EFE1-C2AD-411B-9D32-86EE64B756D2Q35995265-2121A320-1A05-4C6B-ACC8-BAAE3B609414Q36086320-AFBB3C1B-D5DF-4D2F-A650-65FC198DF6CAQ36128825-98CB5C99-10C1-45F1-AAEB-5A2B60C13762Q36613535-40B882BB-D99A-42F3-BD52-A6363CCD6BDBQ36932951-8973B26B-9D3D-4A43-AB68-772DEC12CC68Q38808120-0906F65C-1381-46CB-9A76-A8FB87CA8051Q41642755-764D5A38-5B64-46E0-AC18-68ED4A68F0CAQ41996628-995BC3BA-631E-4B0F-B285-59E125E8243EQ42353177-8688E1D5-1A60-4AF2-859C-D3ECD13F1A9FQ58862216-2FFB347E-E646-4838-B893-21C90A0E710A
P2860
Structure-aided optimization of kinase inhibitors derived from alsterpaullone.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Structure-aided optimization of kinase inhibitors derived from alsterpaullone.
@en
type
label
Structure-aided optimization of kinase inhibitors derived from alsterpaullone.
@en
prefLabel
Structure-aided optimization of kinase inhibitors derived from alsterpaullone.
@en
P2093
P2860
P356
P1433
P1476
Structure-aided optimization of kinase inhibitors derived from alsterpaullone.
@en
P2093
Christoph Schächtele
Conrad Kunick
Daniel Zaharevitz
Frank Totzke
Laurent Meijer
Maryse Leost
Michael H G Kubbutat
Rick Gussio
Thomas Lemcke
Zhihong Zeng
P2860
P304
P356
10.1002/CBIC.200400099
P577
2005-03-01T00:00:00Z